154 related articles for article (PubMed ID: 30187915)
1. Pemphigus foliaceus induced by topical imiquimod treatment.
Shiraishi K; Sayama K
Int J Dermatol; 2018 Dec; 57(12):e155-e157. PubMed ID: 30187915
[No Abstract] [Full Text] [Related]
2. Imiquimod 3.75% for field-directed therapy of actinic keratosis: results of a prospective case-series study in Greece.
Befon A; Tzanetakou V; Panagiotopoulos A; Chasapi V; Antoniou C; Stratigos AJ
Int J Dermatol; 2019 Sep; 58(9):1040-1044. PubMed ID: 30779341
[TBL] [Abstract][Full Text] [Related]
3. Topical Imiquimod in the Treatment of Conjunctival Actinic Keratosis.
Rowlands MA; Giacometti JN; Servat J; Materin MA; Levin F
Ophthalmic Plast Reconstr Surg; 2017; 33(1):e21-e23. PubMed ID: 25853505
[TBL] [Abstract][Full Text] [Related]
4. Imiquimod 5% cream induced psoriasis: a case report, summary of the literature and mechanism.
Patel U; Mark NM; Machler BC; Levine VJ
Br J Dermatol; 2011 Mar; 164(3):670-2. PubMed ID: 21062268
[No Abstract] [Full Text] [Related]
5. Two cases of erosive pustular dermatosis of the scalp occurring after topical 3.75% imiquimod for actinic keratoses.
Giuffrida R; Borgia F; Cannavò SP
Dermatol Ther; 2019 Jan; 32(1):e12770. PubMed ID: 30315627
[No Abstract] [Full Text] [Related]
6. Pemphigus-like eruption as a complication of molluscum contagiosum treatment with imiquimod in a 5-year-old girl.
Zhong CS; Hasbun MT; Jones KM; Schmidt BAR; Hussain SH
Pediatr Dermatol; 2020 Mar; 37(2):379-380. PubMed ID: 32027759
[TBL] [Abstract][Full Text] [Related]
7. Lupus-like reaction following imiquimod treatment for actinic keratoses.
Moreiras Arias N; Buján Bonino C; Pérez Feal P; López-Pardo Rico M; Suárez Peñaranda JM; Vázquez Osorio I
Dermatol Ther; 2022 Sep; 35(9):e15700. PubMed ID: 35801260
[No Abstract] [Full Text] [Related]
8. Use of the back of the hands to apply imiquimod.
Hogan K; Cullan J; Isedeh P; Aires D
J Am Acad Dermatol; 2016 Jan; 74(1):e17. PubMed ID: 26702809
[No Abstract] [Full Text] [Related]
9. Reversible relapse of pemphigus foliaceus triggered by topical imiquimod suggests that Toll-like receptor 7 inhibitors may be useful treatments for pemphigus.
Sebaratnam DF; Martin LK; Rubin AI; Tran K; Pas HH; Marr PJ; Edmonds J; Murrell DF
Clin Exp Dermatol; 2011 Jan; 36(1):91-3. PubMed ID: 20819088
[No Abstract] [Full Text] [Related]
10. Pemphigus vulgaris in adolescence: case report.
Pires FR; Ferraz CC; Alves Fde A; Lopes MA; de Almeida OP
Pediatr Dent; 2000; 22(2):159-62. PubMed ID: 10769865
[TBL] [Abstract][Full Text] [Related]
11. Association between the clinical and histopathological classifications of actinic keratosis and the efficacy of topical imiquimod treatment.
Yu A; Tanizaki H; Kokunai Y; Kaneda K; Sugimoto A; Otsuka T; Kurokawa T; Moriwaki S
J Dermatol; 2018 Apr; 45(4):496-500. PubMed ID: 29265412
[TBL] [Abstract][Full Text] [Related]
12. Development of recalcitrant skin ulcers as a side-effect of treatment with topical 5% imiquimod cream: report of two cases.
Kalampalikis A; Goetze S; Elsner P
J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1574-6. PubMed ID: 24456017
[No Abstract] [Full Text] [Related]
13. [Pemphigus herpetiformis. Description of a case].
Passarini B; Palmerio B; Costa AM; Neri I
G Ital Dermatol Venereol; 1989 Sep; 124(9):411-3. PubMed ID: 2699607
[TBL] [Abstract][Full Text] [Related]
14. [Cytopenia under topical imiquimod in two patients treated with oral hydroxyurea].
Joachim C; Gras-Champel V; Marolleau JP; Chaby G; Dairi M; Carmi E
Ann Dermatol Venereol; 2018 Dec; 145(12):765-768. PubMed ID: 30217687
[TBL] [Abstract][Full Text] [Related]
15. Immune-mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream.
Torres A; Storey L; Anders M; Miller RL; Bulbulian BJ; Jin J; Raghavan S; Lee J; Slade HB; Birmachu W
J Transl Med; 2007 Jan; 5():7. PubMed ID: 17257431
[TBL] [Abstract][Full Text] [Related]
16. Transcriptomic analysis identifies differences in gene expression in actinic keratoses after treatment with imiquimod and between responders and non responders.
Trager MH; Rizk E; Rose S; Zhu K; Lau B; Fullerton BT; Pradhan J; Moore M; Srivastava AC; Singer G; Gartrell R; Chang R; Geskin LJ; Saenger YM; Goldenberg G
Sci Rep; 2021 Apr; 11(1):8775. PubMed ID: 33888854
[TBL] [Abstract][Full Text] [Related]
17. Imiquimod 3.75% cream (Zyclara) for the treatment of actinic keratoses.
Quist SR; Gollnick HP
Expert Opin Pharmacother; 2011 Feb; 12(3):451-61. PubMed ID: 21254950
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Imiquimod 3.75% from Lmax in Actinic Keratosis According to Fitzpatrick Skin Type.
Alomar A; Stockfleth E; Dirschka T; Gupta G; Aractingi S; Dakovic R; Peris K
J Drugs Dermatol; 2016 Mar; 15(3):285-9. PubMed ID: 26954313
[TBL] [Abstract][Full Text] [Related]
19. [Diffuse pruritic eruption].
Khaled A; Gargouri A; Moula H; Fazaa B; Kamoun MR
Ann Dermatol Venereol; 2008; 135(6-7):512-5. PubMed ID: 18598808
[No Abstract] [Full Text] [Related]
20. A 12-Day Course of Imiquimod 5% for the Treatment of Actinic Keratosis: Effectiveness and Local Reactions.
Serra-Guillén C; Nagore E; Llombart B; Sanmartín O; Requena C; Calomarde L; Guillén C
Actas Dermosifiliogr (Engl Ed); 2018 Apr; 109(3):248-253. PubMed ID: 29246367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
